Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] Lymphoma[MeSHID:D008223] leukemia[MeSHID:D007938] |
NA | clinical trial | unknown |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] Lymphoma[MeSHID:D008223] leukemia[MeSHID:D007938] |
NA | phase 1/2 | unknown |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] Lymphoma[MeSHID:D008223] leukemia[MeSHID:D007938] |
NA | phase 1 | unknown |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] |
NA | clinical trial | unknown |
car-t cells targeting bcma | b-cell maturation protein | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1 | unknown |
click here to return to the previous page |